Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Florian Büttner
Observed names:
Büttner, Florian,
Büttner, Florian A.,
F. Büttner,
Florian A Büttner,
Florian A. Büttner,
Florian A. Büttner (15026099)
show all 6
Institutions:
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology,
University of Tübingen
Observed institutions:
German Cancer Research Center,
Helmholtz Munich,
Institute of Bioinformatics and Systems Biology,
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology,
Deutsches Konsortium für Translationale Krebsforschung,
Technical University of Munich,
University of Tübingen
show all 7
ORCID:
0000-0002-0657-9522
Observed ORCID:
0000-0002-0657-9522
OpenAlex ID:
A5046654269
The sufficient minimal set of miRNA seed types
2011
·
Daniel C. Ellwanger
, Florian A. Büttner
, et al.
·
Bioinformatics
·
136
PDF
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
2020
·
Anna Reustle
, Moreno Di Marco
, et al.
·
Genome Medicine
·
90
PDF
Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron
2015
·
Florian Büttner
, Stefan Winter
, et al.
·
European Urology
·
70
Bioengineered Pancreas–Liver Crosstalk in a Microfluidic Coculture Chip Identifies Human Metabolic Response Signatures in Prediabetic Hyperglycemia
2022
·
Reza Zandi Shafagh
, Sonia Youhanna
, et al.
·
Advanced Science
·
60
PDF
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin
2018
·
Elke Schaeffeler
, Florian Büttner
, et al.
·
European Urology Focus
·
60
Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison
2016
·
Patrick Leuthold
, Elke Schaeffeler
, et al.
·
Journal of Proteome Research
·
60
Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma
2018
·
Anna Reustle
, Pascale Fisel
, et al.
·
International Journal of Cancer
·
55
PDF
Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
2016
·
Stefan Winter
, Pascale Fisel
, et al.
·
Scientific Reports
·
49
PDF
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma
2025
·
Tejas Jammihal
, Renee Maria Saliby
, et al.
·
Nature Cancer
·
45
PDF
Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
2022
·
Anna Reustle
, Lena‐Sophie Menig
, et al.
·
Clinical and Translational Medicine
·
45
PDF
Chemogenomic Screening in a Patient‐Derived 3D Fatty Liver Disease Model Reveals the CHRM1‐TRPM8 Axis as a Novel Module for Targeted Intervention
2024
·
Sonia Youhanna
, Aurino M. Kemas
, et al.
·
Advanced Science
·
40
PDF
Wnt/β-catenin and NFκB signaling synergize to trigger growth factor-free regeneration of adult primary human hepatocytes
2023
·
Nuria Oliva-Vilarnau
, Christian M. Beusch
, et al.
·
Hepatology
·
36
Gene Expression Signatures of BRCAness and Tumor Inflammation Define Subgroups of Early-Stage Hormone Receptor–Positive Breast Cancer Patients
2020
·
Werner Schroth
, Florian A. Büttner
, et al.
·
Clinical Cancer Research
·
36
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy
2022
·
Florian A. Büttner
, Stefan Winter
, et al.
·
Genome Medicine
·
35
PDF
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype
2015
·
Werner Schroth
, S. Winter
, et al.
·
Breast Cancer Research and Treatment
·
28
Germline variant burden in multidrug resistance transporters is a therapy‐specific predictor of survival in breast cancer patients
2020
·
Qingyang Xiao
, Yitian Zhou
, et al.
·
International Journal of Cancer
·
27
PDF
mitoBKCa is functionally expressed in murine and human breast cancer cells and potentially contributes to metabolic reprogramming
2023
·
Helmut Bischof
, Selina Maier
, et al.
·
eLife
·
24
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
2018
·
Florian Büttner
, Stefan Winter
, et al.
·
BMC Medicine
·
23
PDF
Profiles of miRNAs matched to biology in aromatase inhibitor resistant breast cancer
2016
·
Reiner Hoppe
, Ping Fan
, et al.
·
Oncotarget
·
16
PDF
Hepatic Expression of the Na+-Taurocholate Cotransporting Polypeptide Is Independent from Genetic Variation
2022
·
Roman Tremmel
, Anne T. Nies
, et al.
·
International Journal of Molecular Sciences
·
14
PDF
Comparative analysis of YAP/TEAD inhibitors in 2D and 3D cultures of primary human hepatocytes reveals a novel non-canonical mechanism of CYP induction
2023
·
Nuria Oliva-Vilarnau
, Sabine U. Vorrink
, et al.
·
Biochemical Pharmacology
·
12
Dendritic Cells or Macrophages? The Microenvironment of Human Clear Cell Renal Cell Carcinoma Imprints a Mosaic Myeloid Subtype Associated with Patient Survival
2022
·
Dorothee Brech
, Anna S. Herbstritt
, et al.
·
Cells
·
12
PDF
Comment on “Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin”
2017
·
Stefan Winter
, Pascale Fisel
, et al.
·
Science Translational Medicine
·
8
Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC
2025
·
Lena-Sophie Menig-Benzig
, Viktoria Stühler
, et al.
·
Pharmacological Research
·
6
A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies
2022
·
Dennis Gürgen
, Michael Becker
, et al.
·
Frontiers in Oncology
·
4
Show more works
View as search
Works count:
73
Citation count:
1,004
H-index:
18
I10-index:
22
Year
Topic
Type